Cargando…

Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study

By September 2022, the uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies have indicated a lower uptake in certain population groups. We aimed to investigate determinants of COVID-19 vaccine uptake in the Netherlands at individual level to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pijpers, Joyce, van Roon, Annika, van Roekel, Caren, Labuschagne, Lisanne, Smagge, Bente, Ferreira, José A., de Melker, Hester, Hahné, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537724/ https://www.ncbi.nlm.nih.gov/pubmed/37766087 http://dx.doi.org/10.3390/vaccines11091409

Ejemplares similares

Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study
por: Pijpers, J, et al.
Publicado: (2023)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis
por: Labuschagne, Lisanne J. E., et al.
Publicado: (2023)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires
por: Mollema, Liesbeth, et al.
Publicado: (2012)

The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study
por: Donken, Robine, et al.
Publicado: (2014)

Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks
por: Smits, Gaby, et al.
Publicado: (2013)

Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
por: Woudenberg, Tom, et al.
Publicado: (2017)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014
por: Suijkerbuijk, Anita W.M., et al.
Publicado: (2015)

The Food Environment Around Primary Schools in a Diverse Urban Area in the Netherlands: Linking Fast-Food Density and Proximity to Neighbourhood Disadvantage and Childhood Overweight Prevalence
por: Smagge, Bente A., et al.
Publicado: (2022)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry
por: Runhart, Esmee H., et al.
Publicado: (2021)

A longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands
por: Alberts, Catharina J., et al.
Publicado: (2017)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
por: de Klerk, Clasine M., et al.
Publicado: (2022)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013–2014
por: van Dam, A.S.G., et al.
Publicado: (2020)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Data-driven development of the nationwide hip fracture registry in the Netherlands
por: Würdemann, Franka S., et al.
Publicado: (2022)

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands
por: Verberk, Janneke Doortje Maria, et al.
Publicado: (2019)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Prevalence and Hospital Admissions in Patients With Osteogenesis Imperfecta in The Netherlands: A Nationwide Registry Study
por: Storoni, Silvia, et al.
Publicado: (2022)

Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands?
por: van Winssen, K. P. M., et al.
Publicado: (2015)

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2010)

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
por: Andeweg, Stijn P, et al.
Publicado: (2023)

Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey
por: van Lier, Alies, et al.
Publicado: (2017)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

Prognosis of patients with dementia: results from a prospective nationwide registry linkage study in the Netherlands
por: van de Vorst, Irene E, et al.
Publicado: (2015)

The dynamics of scarlet fever in The Netherlands, 1906–1920: a historical analysis
por: McDonald, Scott A., et al.
Publicado: (2022)

Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands
por: Vos, Eric R A, et al.
Publicado: (2021)

Regional differences in historical diphtheria and scarlet fever notification rates in The Netherlands, 1905–1925: a spatial-temporal analysis
por: McDonald, Scott A., et al.
Publicado: (2023)

Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study
por: Verschoor, Arie J, et al.
Publicado: (2018)

Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995–96 and 2006–07 in The Netherlands
por: Scherpenisse, Mirte, et al.
Publicado: (2012)

Mumps Vaccine Effectiveness Against Orchitis
por: Hahné, Susan, et al.
Publicado: (2012)

Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
por: Vos, Eric R A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mcjgfvf2np76lje9kj476ao65f